Drug Trial Radar · NCT02051790
Evaluation of Reader Training Processes
Last checked: Nov 19, 2026Latest source record: Sep 28, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
241
Actual
Start
Mar 2014
Primary completion
Aug 2014
Study completion Aug 2014
Sponsor
- Lead sponsor
- Avid RadiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jan 31, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Single group
- Masking
- Single (outcomes assessor)
- Primary purpose
- Diagnostic
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.
Conditions
- Alzheimer's Disease
Interventions
florbetapir F 18Drug
No study drug will be administered in this study - scans previously acquired in the course of clinical practice.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Agreement Between Expert Panel and Clinical Practice ReadsTime frame: Scan acquired 50-60 minutes post injection
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Research Site
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.